Therapure Biopharma Inc. wins a 2013 CMO Leadership Award in All 5 Categories: Quality, Reliability, Innovation, Productivity and Regulatory
Mississauga, ON, [September 11, 2013] – Therapure Biopharma Inc. announced today that its biomanufacturing division, Therapure Biomanufacturing, has won the 2013 CMO Leadership Award as a leader in all five categories: Quality, Reliability, Innovation, Productivity and Regulatory.
The CMO Leadership Award is based on the responses of more than 10,000 pharmaceutical and biopharmaceutical executives in a survey conducted by Nice Insight and presented by Life Science Leader Magazine. The award recognizes contract manufacturing organizations that achieve customer perception scores in the top 20% in the five industry-driven categories. In accepting the 2013 award, Therapure Biopharma Inc. President and Chief Executive Officer, Mr. Nick Green said, “It is an honor to be recognized for a 3rd consecutive year for the CMO Leadership Award, and once again in all five categories. This award recognizes the diligence, passion and contribution of our employees who strive to meet our clients’ needs and produce the highest quality therapeutics possible. The 5 categories are critical to our clients’ success and more importantly for patient well being.” Theapure Biomanufacturing will be recognized as an award winner in the annual CMO Leadership Awards supplement published by Life Science Leader in October. To meet the Therapure Contract Development and Manufacturing Organization (CDMO) team and discuss how they can help you with your biomanufacturing needs, they invite you to visit Therapure at the: • BioProcess International conference, Booth 906, September 17–19th, 2013, in Boston, MA • ContractPharma conference, Booth 10, September 19th, 2013, in New Brunswick, NJ. Therapure Biopharma Inc. is also pleased to announce the launch of its new website, found at www.therapurebio.com. The new website, designed with a fresh new look and user-friendly navigation, reflects the unique business structure of the organization, which is comprised of Therapure Biomanufacturing ( www.therapurebio.com/CDMO ) the award-winning CDMO division, and Therapure Innovations ( www.therapurebio.com/innovations ), the proprietary drug pipeline and platform technology research and development division.
Therapure Biomanufacturing is a global contract development and manufacturing organization (CDMO) offering integrated services for developing, manufacturing, purifying and packaging complex biological therapeutics. Our scientific and manufacturing expertise, as well as our flexible state-of-the-art cGMP facility, provides clients with optimal biomanufacturing solutions to advance their biotherapeutics from discovery to market.
Therapure Biopharma Inc. is an integrated biopharmaceutical company focused on complex biological therapeutics and technologies that can provide new options for patient care. It is comprised of Therapure Biomanufacturing, the award-winning CDMO division and Therapure Innovations, the proprietary drug pipeline and platform technology research and development division. Therapure Biopharma Inc.’s 130,000 sq. ft. cGMP facility includes biomanufacturing, research and quality-control laboratories and is built to meet FDA (USA), HPFB (Canada), EMA (Europe) and MHRA (UK) standards.
For more information, please visit www.therapurebio.com
Director, Marketing and Special Projects
email@example.com (905) 286-6270